[1] Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physiol, 2003, 285(2): H579-H588. [2] 李奎,白育庭. 单次与多次缺血后处理对肺缺血再灌注损伤的实验研究[J]. 临床外科杂志,2008,5(16): 341-343. [3] Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets[J]. Gut, 2003, 52(1): 144-151. [4] Zhao ZQ, Sun HY, Wang NP. Hypoxic postconditioning attenuates cardiomyocyte apoptosis via inhibition of jnk and p38 kinases pathway[J]. J Mol Cell Cardiol, 2005, 38(5): 870. [5] 周正,朱云祥,李强,等. MAPK信号转导通路中ERK、JNK和P38在大鼠肝脏缺血再灌注和缺血后处理中表达的变化[J]. 中国组织工程研究与临床康复, 2009, 13(15): 2919-1922. [6] Sekido N, Mukadia N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8[J]. Nature, 1993, 365(6447): 654-657. [7] Bennett BL, DennisT, Sasaki B, et al. SP600125, anan-thrapyrazolone inhibitor of Jun N-terminal kinase [J]. Proc Natl AcadSci USA, 2001, 98(24) : 13681-13686. [8] 聂君,李劲松,王建军. 肺缺血再灌注损伤的机制和防治进展[J]. 国际移植与血液净化杂志,2007, 5(3):20-25. [9] 朱述阳, 何冰, 穆魁敏, 等. 氧自由基在兔肺缺血再灌注损伤发生中的作用[J]. 中华医学杂志, 1992, 72(6): 370-371. [10]McMillen MA, Huribal M, Sumpio B. Common pathway of endothelial-leukocyte interaction in shock, ishemia and reperfusion[J]. Am J Surg, 1993, 166 (5): 557-562. [11]魏娜,贺海波,张长城,等. JNK信号通路与细胞凋亡关系的研究进展[J]. 中国临床药理学与治疗学,2013, 18(7):807-812. [12]邱晓晓,戴雍月,王万铁,等. SP600125对大鼠肺缺血/再灌注损伤的保护作用及机制[J]. 中国应用生理学杂志,2012, 28(3):255-258. [13]李嫚,王汉民,李苏童,等. 缺血后处理对大鼠肾脏缺血再灌注损伤P38MAPK和JNK的影响[J]. 医学临床研究,2008, 25(7):1170-1173. [14]汪劼,易静. JNK介导的信号转到通路及活性氧在其中的作用[J]. 生命科学,2006, 18(4): 361-367. [15]李芊芊,彭双清. 活性氧对NF-κB活性及JNK信号通路的调节[J]. 生物技术通讯,2008, 19(4): 611-614. [16]仇爱刚. c-jun氨基末端激酶信号通路(JNK)对大鼠肝脏缺血再灌注损伤作用的实验研究[D]. 南京:江苏大学,2010. |